BK polyomavirus genotype IV isolates from virus-specific T-cell therapy recipients
- PMID: 40862351
- PMCID: PMC12509543
- DOI: 10.1128/mra.00625-25
BK polyomavirus genotype IV isolates from virus-specific T-cell therapy recipients
Abstract
BK polyomavirus (BKPyV) can cause disease in transplant recipients. Virus-specific T-cell (VST) therapy is effective in decreasing virus levels in many individuals. BKPyV genetic variation can impact replication kinetics and immune responses. Here, we present the near full-length BKPyV genome sequences from two VST recipients in which genotype IV was isolated.
Keywords: BK polyomavirus; genotype; transplantation; viral diversity; virus-specific T-cell therapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

References
-
- Laskin BL, Denburg MR, Furth SL, Moatz T, Altrich M, Kleiboeker S, Lutzko C, Zhu X, Blackard JT, Jodele S, Lane A, Wallace G, Dandoy CE, Lake K, Duell A, Litts B, Seif AE, Olson T, Bunin N, Davies SM. 2020. The natural history of BK polyomavirus and the host immune response after stem cell transplantation. Clin Infect Dis 71:3044–3054. doi: 10.1093/cid/ciz1194 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources